TriSalus Life Sciences, Inc. (TLSI)

NASDAQ: TLSI · Real-Time Price · USD

7.06

+0.36 (5.37%)

At close: Dec 5, 2025, 4:00 PM EST

7.20

+0.14 (1.98%)

After-hours: Dec 5, 2025, 6:57 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Innovative Drug Delivery Technology and Immune-oncology Therapeutics	18.51M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	18.51M